Skip to main content
Clinical Trials/NCT02627833
NCT02627833
Unknown
Not Applicable

Lungfunction, Lung Clearance Index, Bronchial Inflammation and Epigenetics of Patients With Bronchiolitis Obliterans

Johann Wolfgang Goethe University Hospital1 site in 1 country20 target enrollmentOctober 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bronchiolitis Obliterans
Sponsor
Johann Wolfgang Goethe University Hospital
Enrollment
20
Locations
1
Primary Endpoint
miRNA Status
Last Updated
10 years ago

Overview

Brief Summary

Bronchiolitis obliterans is a chronic disease in which a persistent inflammatory process leads to obliteration of the small airways. Pulmonary function tests (body plethysmography with DLCO, lung clearance index) are performed and the fraction of exhaled nitric oxide is measured. A blood test is following to determine the inflammatory status und collect miRNA. Induced Sputum will be obtained.

Detailed Description

The purpose of this study is to compare miRNA pattern, lung function values, bronchial inflammation and the Lung clearance index of Patients with Bronchiolitis obliterans aged between 6 up to 30 years of age with a matched control group. The sputum samples will be processed and quantitatively analyzed to get a profile of the cytological composition. Sputum and serum samples are analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and by cytometric bead assay (CBA). miRNA samples will be collected, processand compared with the miRNA database at http://www.mirbase.org/ Methods and Work Programme: * Measurement of nitric oxide in expired air (FeNO) * Lung function testing with spirometry and body plethysmography * Lung clearance index (LCI) * Bronchodilation * Blood test: blood count, CRP, RAST, serum inflammatory mediators, (genetic markers of the non-specific pulmonary defense system), miRNA analysis * Induced sputum for inflammatory mediators and microbiological investigations

Registry
clinicaltrials.gov
Start Date
October 2015
End Date
July 2016
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Johann Wolfgang Goethe University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr. med. Martin Rosewich

Principal Investigator

Johann Wolfgang Goethe University Hospital

Eligibility Criteria

Inclusion Criteria

  • informed consent
  • age between 6 an 35 years
  • known bronchiolitis obliterans (Group Bronchiolitis)/ no Bronchiolitis Obliterans (Group matched controls)
  • ability to perform lung function tests and inhale correctly

Exclusion Criteria

  • \<6 years of age
  • \>35 years of age
  • acute systemic or bronchial inflammation
  • other chronic diseases or infection (e.g. HIV, Tbc, malignoma)
  • pregnancy
  • alcohol, drug or illegal drug abuse
  • disability to register the range and consequences of the study
  • actual participation in another study

Outcomes

Primary Outcomes

miRNA Status

Time Frame: single day observation

Blood sample to determine candidate miRNA for Bronchiolitis obliterans

Study Sites (1)

Loading locations...

Similar Trials